GB
GB · GB · GB-APID-39130811000001100
Zeposia 0.23mg/0.46mg capsules treatment initiation pack
ATC L04AE02
Last synced from NHS dm+d (United Kingdom) on
Identification
ManufacturerBristol-Myers Squibb Pharmaceuticals Ltd
CountryGB (GB)
ATC codeL04AE02
Dispensing—
ReimbursedNo
SourceNHS dm+d (United Kingdom)
Last synced6/5/2026
Packs · 2
- gtin5065000521394
- gtin05065000521394
Annotations
No annotations yet.
Raw payload (JSON)
{
"apid": "39130811000001100",
"desc": "Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd)",
"form": "Not applicable",
"vpid": "39149611000001109",
"source": "dmd",
"vtm_id": "871801009",
"strength": null,
"substance": "Ozanimod",
"ingredient": null,
"supplier_code": "3145301000001104"
}Related drugs
Other records sharing ATC code L04AE02.
- ISZeposiaBristol-Myers Squibb Pharma EEIG*
- NOZeposiaBristol-Myers Squibb Pharma EEIG (1)
- 🇨🇭ZeposiaBristol-Myers Squibb SA
- NOZeposiaBristol-Myers Squibb Pharma EEIG (1)
- DKZeposiaBristol-Myers Squibb Pharma EEIG
- ISZeposiaBristol-Myers Squibb Pharma EEIG*
- FIZeposiaBristol-Myers Squibb Pharma EEIG
- NOZeposiaBristol-Myers Squibb Pharma EEIG (1)
Access this data programmatically
Query Zeposia 0.23mg/0.46mg capsules treatment initiation pack and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.